TP53 and central nervous system cancer: Results indicated that lower-grade gliomas with an IDH mutation have either 1p/19q co-deletion or a TP53 mutation, reflecting two distinct molecular mechanisms of oncogenesis; furthermore, no evidence exists for a biological or genetic signature specific to oligoastrocytoma.